agrees – Lab DB

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Apr 18, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier decision regarding Moderna’s investigational mRNA influenza vaccine (mRNA-1010),…

Laboratory Automation & Robotics

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Apr 4, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance on Moderna’s innovative mRNA influenza vaccine candidate,…

Laboratory Automation & Robotics

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Mar 27, 2026 0

In a significant development for vaccine innovation and public health, the U.S. Food and Drug Administration (FDA) has reversed its…

Laboratory Automation & Robotics

FDA reverses course, agrees to review Moderna’s mRNA flu vaccine

Lana Keisha Mar 20, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance, agreeing to review Moderna’s messenger RNA (mRNA)…

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

FDA reverses course, agrees to review Moderna’s mRNA flu vaccine

YOU MAY HAVE MISSED

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition

Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation